Regulatory Affairs

Featured Publication: PLC Life Sciences
Contacts

Tilleke & Gibbins paves the way for life sciences clients to enter and excel in markets throughout Southeast Asia. From research and development and clinical trials to registration and market entry to commercialization and technology transfer, we assist leading and soon-to-be-leading companies through every stage of a product’s life cycle. And when shifting government policies threaten progress, we step in, build coalitions, and facilitate positive change.

Our dynamic group is built on decades of practice in the region and is committed to keeping pace with discovery and innovation. Our client teams are led by experienced attorneys and specialized practitioners and include, as appropriate to the client and its industry, pharmacists, agricultural consultants, and other regulatory specialists. We guide our clients through the layers of formal and informal rules, policies, and procedures, and help our clients forge constructive relationships with regulatory authorities.

Tilleke & Gibbins’ Regulatory Affairs group consistently earns the trust of top companies in the pharmaceutical, cosmetics, consumer products, food and beverages, biotech, medical devices, veterinary products, and other life sciences sectors. Our practice spans the following disciplines:  

  • Clinical Trials and Consumer Testing 
  • Food and Drug Administration (FDA) Registration
  • FDA Import, Export, and Manufacturing Licenses
  • Ministry of Agriculture (MOA) Crop Care Registration
  • MOA Animal, Aquatic, and Hazardous Substance Registration
  • MOA Import, Export, and Manufacturing Licenses
  • Holding Licenses 
  • Regulatory Compliance and Maintenance 
  • Labeling and Advertising Clearance
  • Intellectual Property
Among our recent matters, we have: 
 
  • Acted as counsel to a major pharmaceutical company, which representation included liaising with the Thai FDA on marketing compliance issues, verifying that the client’s marketing activities were in compliance with the complex regulations governing pharmaceutical practice in Thailand, and preventing and mitigating risk and loss.

  • Helped a multinational food company comply with Thai FDA requirements. Advised the client on advertising and promotional materials in Thailand, with particular emphasis on the requirements of the FDA and the consequences of improper ad content.

  • Acted on behalf of a major U.S.-based agrichemical manufacturer. The case involved termination of the client’s distributor for breach of contract and IP (patent and trademark) infringement. In addition, we represented the client in re-registration of its full range of products with the Thai Ministry of Agriculture.

  • Negotiated with the Thai FDA to reclassify a client’s drug product from a new chemical entity (NCE) to new combination (NCO) and secured the successful registration of this product.

  • Answered a critical client inquiry on whether their products could be imported without a certificate of formula disclosure provided to the Customs officer.

  • Secured an export license for the client in an efficient manner, as required by the head of the product group.

  • Coordinated the actions of multiple parties (the reviewers in Thailand, the foreign regulatory affairs authority, and the firm) to timely secure a pharmaceutical product license for the client.

  • Helped an Italian pharmaceutical company prepare an application dossier and obtain a license to operate in the area of medicinal products.

  • Handled a portfolio of products of a pharmaceutical client.  Our representation included assisting in the registration of the products, reviewing and advising on product labels, and assisting in transferring the products to a third company.

  • Secured medical device registration for a top shoe manufacturer and trader in Thailand by giving beneficial advice to the client and working closely with the client to resolve issues with its application. 

  • Registered, in a seamless and efficient manner, a cosmetic product for a large importer in a limited period of time, which enabled the client to timely launch the product.

  • Advised a global pharmaceutical company on all aspects of doing business in Vietnam, including the formation and operation of a representative office, registration as a foreign pharmaceutical company, property transactions, and employment termination and labor disciplinary procedures.

  •   
  • Page :
  • 1
  • 2
Name Position Office Contactsort icon

Paul G. Russell

Of Counsel Bangkok

paul.r@tilleke.com

+66 2653 5540

Pornsroung Saerekul

Regulatory Consultant Bangkok

pornsroung.s@tilleke.com

+66 2653 5606

Atthachai Homhuan

Regulatory Consultant Bangkok

atthachai.h@tilleke.com

+66 2653 5610

Siradapat Ratanakorn

Regulatory Consultant Bangkok

siradapat.r@tilleke.com

+66 2653 5622

Salil Siriwat

Patent Specialist Bangkok

salil.s@tilleke.com

+66 2653 5670

Alan Adcock

Partner Bangkok

alan.a@tilleke.com

+66 2653 5871

Siraprapha Rungpry

Consultant Bangkok

siraprapha.r@tilleke.com

+66 2653 5874

Areeya Pornwiriyangkura

Associate Bangkok

areeya.p@tilleke.com

+66 2653 5882

Darani Vachanavuttivong

Partner Bangkok

darani.v@tilleke.com

+66 2653 5888

Dung Thi Kim Vu

Patent Specialist Hanoi

kimdung.v@tilleke.com

+84 4 3772 5554

  •   
  • Page :
  • 1
  • 2
Date Title
November 13, 2009

Thailand Joins Forces with WHO, Interpol Task Force to Fight Invasion of Counterfeit Drugs

Thailand's pharmaceutical industry is helping inform the citizenry about the dangers of counterfeit medicines as the country joins forces with groups including Interpol, the World Health...

Read more

March 17, 2011

BRT Business Leaders’ Lunch

David Lyman

David Lyman, Chairman & Chief Values Officer of Tilleke & Gibbins, was recently invited to participate in the inaugural BRT Business Leaders Lunch. Held at the JW Marriott in Bangkok, the...

Read more

December 17, 2010

Interview with Cynthia M. Pornavalai on Legal Reform

Cynthia M. Pornavalai

In this interview with Business Report Thailand, Tilleke & Gibbins partner Cynthia M. Pornavalai discusses the possibility of government reform to boost investment. Cynthia examines...

Read more

June 21, 2011

The BigChilli Magazine Interviews David Lyman

David Lyman

The BigChilli, a Bangkok-based lifestyle magazine, recently interviewed David Lyman, Chairman & Chief Values Officer of Tilleke & Gibbins. The interview highlighted the background...

Read more

June 27, 2011

Oxford Business Group Launches The Report: Thailand 2011

David Lyman

In the wake of 2010’s political unrest and with upcoming national elections on the horizon, the climate for business and foreign direct investment in Thailand remains uncertain. The Report:...

Read more

Date Title
August 5, 2009

Market Insight – Clarity Needed Over ASEAN Regulators’ Position

Alan Adcock

The variety and ever-changing nature of regulations governing patent and drug approvals across the Asian region, along with policies which often favor local generics, can pose a daunting challenge...

Read more

July 15, 2009

Combating Infringing Generics

Siraprapha Rungpry

Generic drug manufacturers in Thailand have become particularly active in recent years. There is a clear development trend among local generic producers to catch up with new technology and take...

Read more

May 6, 2011

Beating Cosmetic Product Registration Hurdles

On January 1, 2008, Asean member countries implemented the Asean Harmonization Cosmetics Regulation Scheme in order to harmonize a previously chaotic process. A multitude of confusing laws and...

Read more

May 11, 2011

The Report: Thailand 2011 – Legal Framework

The Report: Thailand 2011, published by Oxford Business Group, provides an in-depth analysis of various sectors of the Thai economy. In the legal section of the publication, Tilleke...

Read more

May 3, 2011

Viewpoint – The Political Scene in Thailand: Pre-Election Observations

David Lyman

In response to regular queries received from our multinational clients, David Lyman, Chairman & Chief Values Officer of Tilleke & Gibbins, has been providing periodic updates on the...

Read more